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FROM THE EDITOR
In September 2016 a woman in her 70s died in Nevada, USA from 
an infection with carbapenem-resistant Enterobacteriaceae (CRE), 
which was resistant to all antibiotics available in the States.[1] The 
woman had apparently returned from an extended trip to India, 
where she had received treatment for a fractured femur and hip 
problems, with multiple hospital admissions. The CRE isolated from 
her wounds in August that year was Klebsiella pneumoniae, which 
proved resistant to all 26 antibiotics that it was tested against. A 
specific enzyme, New Delhi metallo-beta-lactamase, making bac-
teria resistant to a broad range of antibiotics, was detected in one 
of her wounds, according to the Centers for Disease Control and 
Prevention, USA. 
Multidrug-resistant K. pneumoniae has been described by the World 
Health Organization as an ‘urgent threat to human health’. 
In May 2016, international newspapers carried stories of a ‘superbug 
resistant to “antibiotic of last resort”’, which was isolated in the USA. 
The CRE in this instance was isolated from the urine of a 49-year-old 
woman in Pennsylvania. In this case, the bacterium was a strain of 
Escherichia coli resistant to the antibiotic colistin, widely regarded as 
the ‘antibiotic of last choice’. The authors of this article[2] stated that 
‘The recent discovery of a plasmid-borne colistin resistance gene, 
mrc-1, heralds the emergence of a truly pan-drug resistant bacteria’. 
This was the first time that this colistin-resistant strain was found in 
a person in the USA. The woman survived the infection, but someone 
older or with comorbidities may not have done. 
CREs are known in India, now in the USA, and they are right here 
in South Africa.[3] What is particularly worrying is that these resis-
tant strains are being isolated in relatively common infections – an 
apparent osteomyelitis from a femur fracture in an elderly woman 
and from a urinary tract infection in a relatively young woman. The 
story of multidrug- and extreme-drug-resistant tuberculosis is well 
known and has been a problem for many years, albeit with slow buy-
in from the larger pharmaceutical companies in terms of developing 
new treatments. 
But the emergence of resistant strains of more commonly encoun-
tered bacteria in the developed world may change this, as multidrug-
resistant strains of commonly encountered bacteria cause illness and 
death across the world. Metacillin-resistant Staphylococcus aureus 
has been with us for many years now. My father fell prey to it in a 
private Cape Town hospital >6 years ago and I first encountered it 
as a locum in UK hospitals >25 years ago. We did not pay enough 
attention then, and now developing new – and more expensive – anti-
biotics is not the answer. 
Doctors in primary care continue to prescribe, often at the patient’s 
request, unnecessary antibiotics. In hospitals without good infection 
control and antibiotic stewardship policies doctors prescribe inap-
propriate antibiotics – my father was first treated with amoxicillin/
clavulanic acid (Augmentin) when it became obvious that he had a 
severe wound infection. 
We urgently need to stop unnecessary and inappropriate prescrip-
tion of antibiotics across the board. And we also need to put pressure 
on manufacturers of ‘antiseptic’ household cleaners and hand washes 
to stop producing and marketing these. Public education campaigns 
explaining that simple handwashing with ordinary soap and water, 
and that most infections in primary care are self-limiting and caused 
by viruses, are urgently needed. Shocking headlines in newspapers 
about serious hospital infections are not 
sufficient. People need to realise that this 
is something that affects their daily lives 
and could result in the death of a loved one 
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